Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitors

被引：0
|
作者：
Yu-Mu Chen
Chien-Hao Lai
Kun-Ming Rau
Cheng-Hua Huang
Huang-Chih Chang
Tung-Ying Chao
Chia-Cheng Tseng
Wen-Feng Fang
Yu-Hsiu Chung
Yi-Hsi Wang
Mao-Chang Su
Kuo-Tung Huang
Shih-Feng Liu
Hung-Chen Chen
Ya-Chun Chang
Yu-Ping Chang
Chin-Chou Wang
Meng-Chih Lin
机构：
[1] Chang Gung University College of Medicine,Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chang Gung Memorial Hospital
[2] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Kaohsiung Medical Center
[3] Chang Gung University of Science and Technology,Division of Hematology
[4] Chiayi Campus,Oncology, Department of Internal Medicine
来源：
BMC Cancer | / 16卷
关键词：
Neutrophil-to-lymphocyte ratio; Lymphocyte-to-monocyte ratio; Readministration; Non-small cell lung cancer; Epidermal growth factor receptor; Tyrosine kinase inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitors
    Chen, Yu-Mu
    Lai, Chien-Hao
    Rau, Kun-Ming
    Huang, Cheng-Hua
    Chang, Huang-Chih
    Chao, Tung-Ying
    Tseng, Chia-Cheng
    Fang, Wen-Feng
    Chung, Yu-Hsiu
    Wang, Yi-Hsi
    Su, Mao-Chang
    Huang, Kuo-Tung
    Liu, Shih-Feng
    Chen, Hung-Chen
    Chang, Ya-Chun
    Chang, Yu-Ping
    Wang, Chin-Chou
    Lin, Meng-Chih
    BMC CANCER, 2016, 16
  • [2] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Metastatic to the Brain
    Jamal-Hanjani, Mariam
    Spicer, James
    CLINICAL CANCER RESEARCH, 2012, 18 (04) : 938 - 944
  • [3] Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor -mutant non-small cell lung cancer
    Tan, Chee-Seng
    Cho, Byoung-Chul
    Soo, Ross A.
    LUNG CANCER, 2016, 93 : 59 - 68
  • [4] Is there a role for epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor wildtype non-small cell lung cancer?
    Arriola, Edurne
    Taus, Alvaro
    Casadevall, David
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2015, 6 (04): : 45 - 56
  • [5] Epidermal growth factor receptor-mutant non-small cell lung Cancer and Choroidal metastases: long-term outcome and response to epidermal growth factor receptor tyrosine kinase inhibitors
    Bouchez, Clementine
    Pluvy, Johan
    Soussi, Ghassen
    Nguenang, Marina
    Brosseau, Solenn
    Tourne, Morgan
    Collin, Megane
    Theou-Anton, Nathalie
    Guyard, Alice
    Ammar, Jamila
    Khalil, Antoine
    Zalcman, Gerard
    Gounant, Valerie
    BMC CANCER, 2020, 20 (01)
  • [6] Epidermal growth factor receptor-mutant non-small cell lung Cancer and Choroidal metastases: long-term outcome and response to epidermal growth factor receptor tyrosine kinase inhibitors
    Clémentine Bouchez
    Johan Pluvy
    Ghassen Soussi
    Marina Nguenang
    Solenn Brosseau
    Morgan Tourne
    Mégane Collin
    Nathalie Théou-Anton
    Alice Guyard
    Jamila Ammar
    Antoine Khalil
    Gérard Zalcman
    Valérie Gounant
    BMC Cancer, 20
  • [7] Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer
    Asami, Kazuhiro
    Atagi, Shinji
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (04): : 646 - 659
  • [8] Impact of baseline, trend, and normalization of carcinoembryonic antigen on survival in epidermal growth factor receptor-mutant non-small cell lung cancer patients treated with first-line epidermal growth factor receptor tyrosine kinase inhibitors
    Chen, Y. -M.
    Lai, C. -H.
    Lin, M. -C.
    ANNALS OF ONCOLOGY, 2015, 26 : 138 - 138
  • [9] Epidermal growth factor receptor tyrosine kinase inhibitors in elderly patients with non-small cell lung cancer
    Zaarour, Mazen
    Weerasinghe, Chanudi
    Nazha, Bassel
    Hassan, Samer
    Atallah, Jean-Paul
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (11) : 1327 - 1336
  • [10] Neutrophil to Lymphocyte Ratio as a Prognostic Factor in European Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors
    Aguiar-Bujanda, David
    Duenas-Comino, Arancha
    Saura-Grau, Salvador
    Ros-Sanjuan, Laura
    Blanco-Sanchez, Maria J.
    Hernandez-Sosa, Maria
    Mori-De Santiago, Marta
    Galvan-Ruiz, Saray
    Lorenzo-Barreto, Jose E.
    Vargas-Prado, Ana M.
    Bohn-Sarmiento, Uriel
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (12) : 755 - 760
12345